Professor Perry Mark Elliott was born on December 7, 1963, in London.6 He is a Professor of Cardiovascular Medicine at University College London (UCL) and a Senior Investigator of the UK National Institute for Health Research (NIHR).
He is Director of the UCL Centre for Heart Muscle Disease, Head of Clinical Research at the Institute of Cardiovascular Science UCL and a consultant cardiologist in the Centre for Inherited Cardiovascular Disease at the Barts Heart Centre, St. Bartholomew's Hospital London, UK.3
Dr Elliott studied medicine at St. Thomas’s Hospital Medical School, London from 1982 to 1987.
After graduating in 1987 he trained in general medicine. In 1991 he became a member of the Royal College of Physicians and completed his general cardiology training at St. George’s Hospital Medical School, London.
His research focuses on advances in genomic medicine and their application to the diagnosis and management of inherited cardiovascular disease; in particular, he has developed low-cost, high throughput gene sequencing technologies (HTS) that interrogate the entire human genome. These offer enormous opportunities for the advancement of knowledge about human health and disease. He has established an international reputation in the field of heart muscle disease, authoring more than 300 peer-reviewed papers on the subject.
Dr Elliott is the Research Lead of the Inherited Cardiovascular Disease Unit at the Barts Heart Centre and Professor of Cardiovascular Medicine at UCL, where he teaches the Intercalated BSc (Physiology) and Cardiovascular Science MSc programmes. He also does Postgraduate Teaching in the MSc Genomic Medicine programme at Queen Mary University.
In 1999, he was appointed as Senior Lecturer, first at St. George’s Hospital and then at UCL in 2003. While at UCL, he was promoted to Reader in Inherited Cardiac Disease in 2005 and became a Full Professor in 2012. From 2009 to 2013, he was Deputy Editor of The Heart Journal.
Previously, Dr Elliot was Chairman of the ESC Working Group on Myocardial and Pericardial Diseases and has sat on the Executive Committee for the European Outcomes Research Programme (EORP) registry on cardiomyopathies and the ESC Guideline Task Force on Hypertrophic Cardiomyopathy. He develops diagnostic standards, risk stratification tools and clinical service models.2
He is cardiovascular lead for the North Thames NHS Genomic Medicine Centre and a member of the Cardiovascular GeCIP [Cardiomyopathy subgroup] and Genomics England Pilot Steering Committee. He is also an associate editor for the Journal of American College of Cardiology and President of Cardiomyopathy UK.3 Dr Elliot has edited two books: Principles and Practice of Clinical Cardiovascular Genetics in 2010 and Inherited Cardiac Disease (Oxford Specialist Handbooks in Cardiology) in 2011.4
He is a visiting lecturer at the Hadassah Hospital in Israel, Calgary Hospital in Canada and the Bangalore Genetics Institute in India. He regularly speaks at educational courses, symposia and international congresses in Europe and North America.
- 1999: Senior Lecturer, St. George’s Hospital
- 2003: Senior Lecturer, UCL
- 2005: Reader in Inherited Cardiac Disease, UCL
- 2005: Fellow, European Society of Cardiology (ESC)
- 2009 - 2013: Deputy Editor, The Heart Journal
- 2010 - 2012: Chairman, ESC Working Group on Myocardial and Pericardial Diseases
- 2012: Full Professor, Inherited Cardiovascular Disease, UCL
- 2013: Visiting Professor, Cleveland Clinic, Ohio
- 2003 - Present: Professor of Cardiovascular Medicine, UCL
- 2015 - Present: Consultant Cardiologist, St. Bartholomew's Hospital (Barts Health), London
- 2017 - Present: Head of Clinical Research, UCL Institute of Cardiovascular Science
- 2017 - Present: President, Cardiomyopathy UK
- 2018 - Present: Chairman ESC Heart Academy
- 2019 - Present: Chairman, European Society of Cardiology Council on Cardiovascular Genomics
- 2020 - Present: Executive Editor, European Heart Journal
Areas of Speciality4
- Heart Failure
Dr Elliot is on the ECR Editorial Board.